Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene marking

M Brenner1

  • 1Division of Bone Marrow Transplantation, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Human Gene Therapy
|October 20, 1996
PubMed
Summary
This summary is machine-generated.

Gene marking studies track hematopoietic stem cells, providing insights into gene transfer and disease relapse. Future research needs improved, non-altering marker genes for broader applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanical ventilation for young people with Duchenne muscular dystrophy: a factorial survey of the main influences on clinician decision-making.

European journal of pediatrics·2025
Same author

Navigating healthcare decision-making for children requiring life-sustaining medical treatment in Ireland: exploring clinician perspectives through the lens of the Irish legal system.

BMC medical ethics·2025
Same author

Correction: Sediment biomarkers elucidate the Holocene ontogeny of a shallow lake.

PloS one·2018
Same author

Sediment biomarkers elucidate the Holocene ontogeny of a shallow lake.

PloS one·2018
Same author

Research priorities for specialized nursing practice in the United Arab Emirates.

International nursing review·2017
Same author

Tackling the burden of the hepatitis C virus in the UK: characterizing and assessing the clinical and economic consequences.

Public health·2016
Same journal

Genome Editing for Familial Hemophagocytic Lymphohistiocytosis: Design Principles, Challenges, and Translational Perspectives.

Human gene therapy·2026
Same journal

Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration.

Human gene therapy·2026
Same journal

Hyperthermia-Enhanced Adeno-Associated Virus Gene Therapy: Mechanisms, Delivery Technologies, and Translational Potential.

Human gene therapy·2026
Same journal

Adeno-Associated Virus Gene Therapy Translation: Lessons from Early Regulatory Meetings.

Human gene therapy·2026
Same journal

In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>.

Human gene therapy·2026
Same journal

<i>In Vivo</i> Genome Editing Approach to Disrupt Hydroxyacid Oxidase 1 for the Treatment of Primary Hyperoxaluria Type 1.

Human gene therapy·2026
See all related articles

Area of Science:

  • * Molecular Biology
  • * Gene Therapy
  • * Stem Cell Biology

Background:

  • * Gene marking studies represent the initial clinical applications of gene transfer technologies.
  • * Current studies predominantly focus on hematopoietic stem cells and their derivatives.
  • * These studies have yielded crucial data on stem cell behavior, gene transfer efficacy, and relapse mechanisms in malignant diseases.

Purpose of the Study:

  • * To review the utility and limitations of current gene marking strategies.
  • * To highlight the need for improved marker elements in future gene transfer applications.
  • * To discuss the safety and ongoing follow-up of patients in gene marking trials.

Main Methods:

  • * Retrospective analysis of published gene marking studies.

Related Experiment Videos

  • * Review of clinical trial data focusing on hematopoietic stem cell transplantation.
  • * Evaluation of marker gene characteristics and their impact on cellular function.

    • Main Results:

    • * Gene marking has provided significant insights into stem cell biology and disease relapse.
    • * Second-generation studies are expanding the scope of clinical and biological investigations.
    • * Existing indicator genes possess undesirable traits that limit future applications.
    • * Current marker studies have demonstrated an acceptable safety profile to date.

    Conclusions:

    • * Gene marking studies have been instrumental in advancing stem cell research and therapy.
    • * The development of novel marker elements is essential for future gene transfer protocols.
    • * Continued patient follow-up is necessary to fully assess the long-term safety of gene marking.